Nanobac Pharmaceuticals, Incorporated Financial Ratios — NNBP

Profitability (USD)

	1994 Y	1995 Y	1996 Y	1997 Y	1998 Y	1999 Y	2002 Y	2003 Y	2004 Y	2005 Y	2006 Y	2007 Y
As of date	12/31/1994	12/31/1995	12/31/1996	12/31/1997	12/31/1998	12/31/1999	12/31/2002	12/31/2003	12/31/2004	12/31/2005	12/31/2006	12/31/2007

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-12.4	-15.33	-22.07	-36.3	-45.04	-53.5	-122.31	-108.32	-39.53	-59.23	-87.42
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	56.76	43.55	45.36	46.38	38.62	35.53	62.65	31	71.96	65.07	64.54	17.6
EBITDA Margin (%)	29.73	1.61	5.07	2.06	-8.21	-19.47	-12,767.62	-521.75	-1,920.78	-316.34	-1,898.5	-25,279.55
Operating Margin (%)	13.51	-12.9	-8.56	-12.48	-23.36	-34.6	-12,767.62	-559.26	-2,120.87	-432.05	-2,138.98	-27,891.78
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	-16.13	-13.99	-19.21	-30.54	-40.02	-12,767.62	-572.55	-2,361.07	-561.41	-2,209.53	-37,319.74
Profit Margin (%)	2.7	-12.9	-13.99	-19.21	-30.54	-40.02	-12,767.62	-766.23	-2,377.05	-561.41	-2,209.53	-37,319.74
Net Income to Common Margin (%)	2.7	-12.9	-13.99	-19.21	-30.54	-40.02	-12,767.62	-766.23	-2,377.05	-561.41	-2,209.53	-37,319.74
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	1994 Y	1995 Y	1996 Y	1997 Y	1998 Y	1999 Y	2002 Y	2003 Y	2004 Y	2005 Y	2006 Y	2007 Y
As of date	12/31/1994	12/31/1995	12/31/1996	12/31/1997	12/31/1998	12/31/1999	12/31/2002	12/31/2003	12/31/2004	12/31/2005	12/31/2006	12/31/2007

Total Debt	3	4	6	6	5	5	- -	6	- -	2	5	4
ST Debt	1	1	2	6	3	5	- -	6	- -	2	5	4
LT Debt	2	3	4	1	2	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	2.91	42	13.93	29.98	-7.3	-3.53	- -	-2.27	-0.04	-1.2	-1.26	-0.93
Net Debt/EBITDA	1.55	41	3.58	11.32	-3.22	-1.37	- -	-2.25	-0.03	-1.19	-1.25	-0.92
Total Debt/EBIT	6.4	-5.25	-8.26	-4.95	-2.56	-1.98	- -	-2.12	-0.03	-0.88	-1.11	-0.84
Net Debt/EBIT	3.4	-5.12	-2.12	-1.87	-1.13	-0.77	- -	-2.1	-0.03	-0.87	-1.11	-0.84
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-8.47	-11.43	-22.26	-48.8	-99.75	-170.18	-6,527.32	-15.57	26.88	-193.77	-285.68	-400.71
Long-Term Debt/Equity (%)	125	230.77	1,492.09	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	92.59	88.24	96.32	27.25	2,263.9	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	42.37	42.86	44.28	7.33	32.12	- -	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	160	323.08	2,299.07	-579.93	-171.57	-90.62	- -	-710.78	4.2	100.85	-409.19	-174.49
Total Debt/Capital (%)	118.52	123.53	148.41	281.51	5,567.28	-146.79	- -	111.49	8.97	-16.69	-31.6	-16.62
Total Debt/Total Assets (%)	54.24	60	68.23	75.69	79	85.3	- -	94.8	2.65	27.71	68.59	57.09
Net Debt to Equity	85	315.38	591.21	-218.91	-75.71	-35.21	- -	-704.61	3.9	100.48	-406.18	-174.33
Net Debt/Capital (%)	141.67	124.24	39.13	106.26	2,456.78	-57.04	- -	111.6	8.39	-16.62	-31.29	-16.6
EBITDA	1	- -	- -	- -	-1	-1	-1	-3	-7	-2	-4	-4
EBITDA-CapEx	1	-1	- -	- -	-1	-1	-1	-3	-7	-2	-4	-4
Operating Income (Loss)	- -	-1	-1	-1	-2	-2	-1	-3	-8	-3	-5	-5

Liquidity (USD)

API ChatGPT

	1994 Y	1995 Y	1996 Y	1997 Y	1998 Y	1999 Y	2002 Y	2003 Y	2004 Y	2005 Y	2006 Y	2007 Y
As of date	12/31/1994	12/31/1995	12/31/1996	12/31/1997	12/31/1998	12/31/1999	12/31/2002	12/31/2003	12/31/2004	12/31/2005	12/31/2006	12/31/2007

Cash Ratio	1.25	0.04	0.02	- -	- -	- -	- -	0.01	0.01	- -	0.01	- -
Current Ratio	1.83	0.76	0.53	0.26	0.27	0.2	0.02	0.01	0.09	0.05	0.02	- -
Quick Ratio	1.75	0.64	0.48	0.25	0.26	0.02	0.02	0.01	0.02	- -	0.01	- -
CFO/Avg Current Liab	- -	-0.16	0.13	0.07	0.07	-0.01	-0.19	-0.6	-0.83	-0.95	-0.52	-0.14
Common Equity/Total Assets	-8.47	-11.43	-22.26	-48.8	-99.75	-170.18	-6,527.32	-15.57	26.88	-193.77	-285.68	-400.71
Long-Term Debt/Equity (%)	125	230.77	1,492.09	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	92.59	88.24	96.32	27.25	2,263.9	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	42.37	42.86	44.28	7.33	32.12	- -	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	160	323.08	2,299.07	-579.93	-171.57	-90.62	- -	-710.78	4.2	100.85	-409.19	-174.49
Total Debt/Capital (%)	118.52	123.53	148.41	281.51	5,567.28	-146.79	- -	111.49	8.97	-16.69	-31.6	-16.62
Total Debt/Total Assets (%)	54.24	60	68.23	75.69	79	85.3	- -	94.8	2.65	27.71	68.59	57.09
CFO/Total Liabilities	17.95	-5.26	5.2	4.65	5.43	-0.68	-309.02	-31.46	-95.03	-36.36	-28.29	-9.51
CFO/CapEx	1.75	-0.25	0.59	1.73	10.96	-0.52	- -	-118.7	-92.36	-58.21	-202.59	-594.19
Altman's Z-Score	1.06	0.26	0.18	-0.85	-2.04	-4.16	-1,343.07	-77.4	-143.15	-123.1	-220.04	-837.92

Working Capital (USD)

API ChatGPT

	1994 Y	1995 Y	1996 Y	1997 Y	1998 Y	1999 Y	2002 Y	2003 Y	2004 Y	2005 Y	2006 Y	2007 Y
As of date	12/31/1994	12/31/1995	12/31/1996	12/31/1997	12/31/1998	12/31/1999	12/31/2002	12/31/2003	12/31/2004	12/31/2005	12/31/2006	12/31/2007

Accounts Receivable Turnover	- -	- -	8.33	4.75	4.37	6.38	0.12	87.88	78.24	196.71	112.8	13.68
Days Sales Outstanding	- -	- -	43.82	76.91	83.56	57.18	3,014.43	4.15	4.66	1.86	3.24	26.69
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	41.1	2.32	2.44	0.87	0.38
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	8.88	157.64	149.42	419.93	963.53
Accounts Payable Turnover	- -	6.36	5.77	3.9	3.06	2.18	- -	0.69	0.22	0.58	0.08	-0.06
Accounts Payable Turnover Days	- -	57.36	63.22	93.66	119.24	167.21	103,327.69	531.05	1,647.95	634.05	4,566.75	-6,534.64
Cash Conversion Cycle	- -	-57.36	-19.41	-16.75	-35.68	-110.03	-100,313.25	-518.02	-1,485.65	-482.77	-4,143.58	7,524.87
Inventory to Cash Days	- -	- -	43.82	76.91	83.56	57.18	3,014.43	-4.73	-152.97	-147.56	-416.7	-936.84
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	1994 Y	1995 Y	1996 Y	1997 Y	1998 Y	1999 Y	2002 Y	2003 Y	2004 Y	2005 Y	2006 Y	2007 Y
As of date	12/31/1994	12/31/1995	12/31/1996	12/31/1997	12/31/1998	12/31/1999	12/31/2002	12/31/2003	12/31/2004	12/31/2005	12/31/2006	12/31/2007

Market Capitalization	- -	- -	1	- -	1	5	35	47	22	7	24	- -
- Cash & Cash Equivalents	2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	1	1	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	3	4	6	6	5	5	- -	6	- -	2	5	4
Enterprise Value	2	4	7	7	7	11	35	53	22	9	29	4
Total Capital	3	3	4	2	- -	-3	- -	5	3	-15	-17	-25
Total Debt/Capital (%)	118.52	123.53	148.41	281.51	5,567.28	-146.79	- -	111.49	8.97	-16.69	-31.6	-16.62
Total Debt / EV	1.88	1.02	0.86	0.94	0.71	0.43	- -	0.11	0.01	0.26	0.18	1
EV/Sales	0.46	0.66	0.83	0.66	0.84	1.61	3,026.41	108.94	62.53	14.41	129.99	233.7
EV/EBITDA	1.55	41	16.29	31.91	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	3.4	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	15.8	15.33	13.97	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	4.56	5.83	9.71	12.8	161.37	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	1	- -	1	5	63	47	22	7	24	- -
Diluted Enterprise Value	2	4	7	7	7	11	63	53	22	9	29	4
EV per Share	- -	- -	11.38	8.27	3.32	4.97	1.75	0.78	0.15	0.05	0.15	- -
TTM Sales	4	6	9	10	9	7	- -	- -	- -	1	- -	- -
TTM EBITDA	1	- -	- -	- -	-1	-1	-1	-3	-7	-2	-4	-4
TTM Operating Income	- -	-1	-1	-1	-2	-2	-1	-3	-8	-3	-5	-5
TTM Cash Flow to Firm	- -	- -	- -	- -	1	- -	-1	-2	-3	-2	-3	-1
TTM Free Cash Flow to Firm	- -	1	1	1	1	- -	-1	-2	-3	-2	-3	-1

Multiples (USD)

API ChatGPT

	1994 Y	1995 Y	1996 Y	1997 Y	1998 Y	1999 Y	2002 Y	2003 Y	2004 Y	2005 Y	2006 Y	2007 Y
As of date	12/31/1994	12/31/1995	12/31/1996	12/31/1997	12/31/1998	12/31/1999	12/31/2002	12/31/2003	12/31/2004	12/31/2005	12/31/2006	12/31/2007

Price/Free Cash Flow	- -	- -	0.93	0.59	1.12	71.08	-59.31	-21.79	-6.6	-3.01	-9.3	- -
EV/EBIT	3.4	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	2	4	7	7	7	11	35	53	22	9	29	4
Low Price	3	1	1.69	0.44	0.26	0.29	0.02	0.22	0.12	0.04	0.01	0.04
EV/Sales	0.46	0.66	0.83	0.66	0.84	1.61	3,026.41	108.94	62.53	14.41	129.99	233.7
EV/EBITDA	1.55	41	16.29	31.91	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-1.5	-0.54	-0.7	-0.88	-2.47	-13.82	-6.55	-4.58	-4.13	- -
Price/Earnings High	- -	- -	-2.34	-1.01	-1.56	-2.43	-67.73	-31.93	-17.05	-8.45	-14.24	- -
Price/Earnings Low	- -	- -	-0.88	-0.18	-0.22	-0.24	-0.27	-4.01	-2.24	-1.9	-0.44	- -
Price/Book Value	- -	- -	-0.57	-0.1	-0.1	-0.52	-102.58	-49.49	8.52	-0.4	-1.07	- -
Price/Book Value Average	- -	- -	-0.91	-0.26	-0.28	-0.26	-10.69	-54.35	21.45	-0.97	-0.92	- -
Price/Book Value High	- -	- -	-1.42	-0.49	-0.63	-0.71	-293.07	-125.51	55.8	-1.79	-3.17	- -
Price/Book Value Low	- -	- -	-0.53	-0.09	-0.09	-0.07	-1.17	-15.78	7.34	-0.4	-0.1	- -
Price/Tangible Book Value	- -	- -	4.28	-0.37	-0.14	-0.73	-102.58	-6.74	-6.79	-1.13	-2.69	- -
Price/Tangible Book Value Average	- -	- -	6.83	-0.97	-0.41	-0.36	-10.69	-7.4	-17.1	-2.72	-2.31	- -
Price/Tangible Book Value High	- -	- -	10.63	-1.82	-0.92	-1	-293.07	-17.1	-44.49	-5.02	-7.96	- -
Price/Tangible Book Value Low	- -	- -	3.99	-0.33	-0.13	-0.1	-1.17	-2.15	-5.85	-1.13	-0.25	- -
Price/Sales	- -	- -	0.13	0.04	0.07	0.71	3,026.41	96.45	61.87	10.64	106.32	- -
Price/Sales Average	- -	- -	0.21	0.1	0.21	0.35	315.28	105.93	155.8	25.71	91.17	- -
Price/Sales High	- -	- -	0.33	0.19	0.48	0.97	8,646.89	244.62	405.34	47.44	314.53	- -
Price/Sales Low	- -	- -	0.12	0.03	0.07	0.09	34.59	30.75	53.33	10.64	9.75	- -
Price/Cash Flow	- -	- -	2.51	0.93	1.22	-66.89	-32.69	-21.61	-6.53	-2.95	-9.26	- -
Price/Cash Flow Average	- -	- -	4.01	2.41	3.53	-33	-3.41	-23.73	-16.44	-7.14	-7.94	- -
Price/Cash Flow High	- -	- -	6.25	4.52	7.9	-91.62	-93.41	-54.8	-42.78	-13.17	-27.39	- -
Price/Cash Flow Low	- -	- -	2.35	0.81	1.09	-8.86	-0.37	-6.89	-5.63	-2.95	-0.85	- -
Price/Free Cash Flow Average	- -	- -	1.48	1.53	3.24	35.07	-6.18	-23.93	-16.62	-7.26	-7.98	- -
Price/Free Cash Flow High	- -	- -	2.31	2.86	7.24	97.38	-169.45	-55.26	-43.24	-13.4	-27.52	- -
Price/Free Cash Flow Low	- -	- -	0.87	0.51	1	9.41	-0.68	-6.95	-5.69	-3.01	-0.85	- -
EV/Sales Average	0.46	0.66	0.91	0.72	0.98	1.25	315.28	118.42	156.47	29.48	114.84	233.7
EV/Sales High	0.46	0.66	1.02	0.81	1.24	1.88	8,646.89	257.11	406.01	51.22	338.2	233.7
EV/Sales Low	0.46	0.66	0.82	0.65	0.83	1	34.59	43.24	54	14.41	33.42	233.7
EV/EBITDA Average	1.55	41	17.84	35	-11.94	-6.43	-2.47	-22.7	-8.15	-9.32	-6.05	-0.92
EV/EBITDA High	1.55	41	20.14	39.4	-15.14	-9.63	-67.73	-49.28	-21.14	-16.19	-17.81	-0.92
EV/EBITDA Low	1.55	41	16.12	31.67	-10.15	-5.12	-0.27	-8.29	-2.81	-4.56	-1.76	-0.92
EV/EBIT Average	3.4	-5.12	-10.58	-5.77	-4.19	-3.62	-2.47	-21.17	-7.38	-6.82	-5.37	-0.84
EV/EBIT High	3.4	-5.12	-11.94	-6.5	-5.32	-5.42	-67.73	-45.97	-19.14	-11.85	-15.81	-0.84
EV/EBIT Low	3.4	-5.12	-9.56	-5.23	-3.57	-2.88	-0.27	-7.73	-2.55	-3.34	-1.56	-0.84
Last Price	4.75	3.13	1.81	0.5	0.29	2.19	1.75	0.69	0.14	0.04	0.12	0.05
High Price	4.94	6.25	4.5	2.44	1.88	3	5	1.75	0.95	0.16	0.36	0.17
Enterprise Value Average	2	4	8	7	9	9	4	57	56	19	26	4
Enterprise Value High	2	4	9	8	11	13	100	124	145	34	76	4
Enterprise Value Low	2	4	7	6	7	7	- -	21	19	9	8	4

Shares Outstanding	- -	- -	1	2	2	2	20	100	186	189	247	247
Diluted Weighted Avg Shares	- -	- -	1	1	2	2	36	67	153	189	199	- -
Basic Weighted Avg Shares	- -	- -	1	1	2	2	20	67	153	189	199	- -
Revenue per Share	- -	- -	13.77	12.59	3.95	3.08	- -	0.01	- -	- -	- -	- -
EBITDA per Share	- -	- -	0.7	0.26	-0.32	-0.6	-0.07	-0.04	-0.05	-0.01	-0.02	- -
Operating Income per Share	- -	- -	-1.18	-1.57	-0.92	-1.07	-0.07	-0.04	-0.05	-0.02	-0.02	- -
Basic EPS, GAAP	- -	- -	-1.93	-2.42	-1.21	-1.23	-0.07	-0.05	-0.06	-0.02	-0.02	- -
Basic EPS from Cont Ops	- -	- -	-1.93	-2.42	-1.21	-1.23	-0.07	-0.04	-0.06	-0.02	-0.02	- -
Diluted EPS, GAAP	- -	- -	-1.93	-2.42	-1.21	-1.23	-0.04	-0.05	-0.06	-0.02	-0.02	- -
Diluted EPS from Cont Ops	- -	- -	-1.93	-2.42	-1.21	-1.23	-0.04	-0.04	-0.06	-0.02	-0.02	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	- -	0.72	0.54	0.24	-0.03	-0.05	-0.03	-0.02	-0.01	-0.01	- -
Free Cash Flow per Basic Share	- -	- -	-0.51	0.23	0.22	-0.1	-0.05	-0.03	-0.02	-0.01	-0.01	- -
Cash & Equivalents per Share	- -	- -	0.16	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	- -	- -	-3.18	-5.01	-2.99	-4.22	-0.02	-0.01	0.02	-0.09	-0.11	- -
Tangible Book Value per Share	- -	- -	0.42	-1.34	-2.04	-3	-0.02	-0.1	-0.02	-0.03	-0.04	- -

Nanobac Pharmaceuticals, Incorporated

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)